Initial experience with minimally invasive treatment of pilonidal sinus in children

Vojtech Dotlacil1, Michal Rygl1, Barbora Frybova1

  • 1Department of Paediatric Surgery, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.

Insights

Minimally invasive endoscopic treatment of pilonidal sinus (PEPSiT) shows promise for pediatric patients, offering a safe and well-tolerated option with quick recovery and low pain. Two recurrences were successfully managed with repeat PEPSiT procedures.

Area of Science:

  • Pediatric Surgery
  • Minimally Invasive Procedures
  • Inflammatory Diseases

Background:

  • Sinus pilonidalis (SP) is a common acquired inflammatory condition in children.
  • Surgical intervention is typically required for symptomatic cases.
  • Minimally invasive pilonidal sinus treatment (EPSiT) was adapted for pediatric use in 2017.

Purpose of the Study:

  • To assess the initial clinical experience with pediatric endoscopic pilonidal sinus treatment (PEPSiT) in the Czech Republic.
  • To evaluate the safety and efficacy of PEPSiT in a pediatric and adolescent cohort.
  • To analyze perioperative outcomes, complications, and recurrence rates associated with PEPSiT.

Main Methods:

  • Retrospective analysis of pediatric patients undergoing PEPSiT between November 2018 and February 2020.
  • Data collection included demographics, surgical details, hospital stay, complications, healing, and recurrence.
  • Patient-reported pain was assessed using the Visual Analog Scale (VAS).

Main Results:

  • Seventeen pediatric patients (median age 17.1 years, 76% male) were included.
  • The median PEPSiT duration was 50 minutes, with no postoperative complications reported within 30 days.
  • Fourteen of fifteen patients achieved healing, with two recurrences successfully treated by re-PEPSiT.

Conclusions:

  • PEPSiT is a highly promising, safe, and well-tolerated treatment for pediatric sinus pilonidalis.
  • The procedure facilitates a short hospital stay and rapid return to normal activities with minimal pain.
  • Repeat PEPSiT (re-PEPSiT) is an effective option for managing disease recurrence.
Abstract